Herantis Pharma Oyj Stock Forecast for 2023 - 2025 - 2030
Updated on 04/23/2024
Herantis Pharma Oyj Stock Forecast and Price Target
The average target price for Herantis Pharma Oyj's stock set by renowned analysts in recent months is 2.90€, representing a potential upside of approximately 100% from its last closing price if met by 2025. This estimation is based on a high estimate of 2.90€ and a low estimate of 2.90€.
100.00% Upside
.jpg)
Herantis Pharma Oyj EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Herantis Pharma Oyj's EBITDA has grown by 11.90%, rising from -7.14€M to -7.99€M. For next year, analysts predict EBITDA of -9.83€M, which would mean an increase of 23.06%. Over the next eight years, experts predict that Herantis Pharma Oyj's EBITDA will grow at a rate of 26.38%.
Herantis Pharma Oyj EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Herantis Pharma Oyj's EBIT has grown, rising from -8.07€M to 150.00€k – a growth of 101.86%. For the next year, 0 analysts project Herantis Pharma Oyj's EBIT to drop by 1801.99%, reaching -2.55€M. By 2030, professionals believe that Herantis Pharma Oyj's EBIT will decrease by 669790.04%, reaching -1.00€B – a concerning trend for the company.
.jpg)